PDF herunterladen
Aktuelle Ernährungsmedizin 2002; 27(3): 172-181
DOI: 10.1055/s-2002-32277
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Ernährungstherapie der Dyslipoproteinämien

Nutritional Therapy of DyslipoproteinaemiasG.  Wolfram1
  • 1Institut für Ernährungswissenschaft, Techn. Universität München
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
18. Juni 2002 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Dyslipoproteinämien sind in der Bevölkerung weit verbreitet und gehen mit einem erhöhten Koronarrisiko einher. Bis auf seltene Formen sind die Dyslipoproteinämien durch Ernährungstherapie beeinflussbar. Eine vollwertige Ernährung ist deshalb die Basis jeder Therapie einer Fettstoffwechselstörung. Die ernährungstherapeutischen Maßnahmen zielen auf eine Senkung des LDL-Cholesterins durch eine fettreduzierte und fettmodifizierte Ernährung ab. Niedrige HDL-Cholesterinwerte sind bevorzugt durch Gewichtsreduktion und vermehrte körperliche Aktivität anzuheben. Hyperchylomikronämien werden durch den Einsatz von mittelkettigen Triglyzeriden und erhöhte VLDL-Triglyzeride durch Gewichtsreduktion und vernünftigen Umgang mit Süßigkeiten und Alkohol behandelt. Über den Einfluss auf die Lipoproteine im Plasma hinaus wirken die verschiedenen Fettsäuren auch auf weitere für die Atherogenese wichtige Faktoren, wie die Blutviskosität, die Thrombozytenaggregation, den Blutdruck bis hin zur Genexpression von Zytokinen. Durch eine erhöhte Zufuhr von n-3 Fettsäuren können tödliche Infarkte verhindert und die Lebenserwartung erhöht werden. Weitere Nahrungsfaktoren, wie antioxidative Vitamine, sekundäre Pflanzenstoffe und Ballaststoffe haben ebenfalls eine koronarprotektive Wirkung. Bei Patienten mit Dyslipoproteinämie sollten die Lipoproteine im Plasma nicht die einzigen Zielgrößen sein. Vielmehr sollte das präventive Potenzial einer vollwertigen Ernährung unter Bevorzugung von Lebensmitteln pflanzlicher Herkunft und konsequenter Umsetzung einer fettmoderaten und fettmodifizierten Ernährung in Kombination mit ausreichender körperlicher Aktivität insgesamt genutzt werden.

Abstract

Dyslipoproteinaemias are common and are associated with an enhanced risk of coronary heart disease. Generally, with only rare exceptions, their course may be influenced by nutritional therapy. Hence, any treatment of dyslipoproteinaemias must, first of all, lower LDL cholesterol levels by reducing and modifying fat in the diet. Lower HDL cholesterol levels are achieved by reducing the body weight and via enhanced physical activity. Hyperchylomicroaemias are treated by means of medium-chain triglycerides and enhanced VLDL triglycerides by weight reduction and a moderate intake of sweets and alcohol. Various fatty acids do not only influence lipoproteins in the blood plasma; they also act on other factors that are of importance in atherogenesis, such as viscosity of the blood, thrombocyte aggregation, blood pressure and even the gene expression of cytokines. Fatal infarctions can be prevented and life expectancy increased by enhanced supply of n-3 fatty acids. Other nutritional factors are also coronary protectors, such as antioxidative vitamins, secondary plant constituents and dietary fibres. The plasma lipoproteins should not be the only targets in the treatment of dyslipoproteinaemia; it is essential to fully utilise the preventive potentials of wholefood nutrition prominently featuring food from the plant kingdom and of a single-minded pursuit of a diet with moderate and modified fats, combined at the same time with adequate physical activity.

Literatur

  • 1 Anderson J W, Johnstone B, Coo-Newell M. Meta-Analysis of the effects of soy protein intake on serum lipids.  N Engl J Med. 1995;  333 276-282
    CrossrefPubMedGoogle Scholar
  • 2 Astrup A. The role of dietary fat in the prevention and treatment of obesity. Efficacy and safety of low-fat diets.  International Journal of Obesity. 2001;  25 546-550
    PubMedGoogle Scholar
  • 3 Bak A A, Grobbe D E. The effect on serum cholesterol levels of coffee brewed by filtering or boiling.  N Engl J Med. 1989;  321 1432-1437
    CrossrefPubMedGoogle Scholar
  • 4 Baumann K, Hessel F, Larass I, Müller T, Angerer P, Kiefl R, von Schacky C. Dietary n-3, n-6, and n-9 Unsaturated Fatty Acids and Growth Factor and Cytokine Gene Expression in Unstimulated and Stimulated Monocytes.  Arterioscler Thromb Vasc Biol. 1999;  19 59-66
    PubMedGoogle Scholar
  • 5 Beynen A C, Katan M B, van Zutphen B FM. Individuelle Unterschiede der Serumcholesterinreaktion auf Änderungen der Ernährungsform.  Ernährungs-Umschau. 1985;  32 356-360
    PubMedGoogle Scholar
  • 6 Blair S N, Kohl H W, Paffenberger R S, Clark D G, Cooper K H, Gibbons L W. Physical Fitness and All-Cause Mortality of a Prospective Study of Healthy Men and Women.  JAMA. 1989;  262 2395-2401
    CrossrefPubMedGoogle Scholar
  • 7 Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study.  Epidemiology. 1990;  1 342-348
    PubMedGoogle Scholar
  • 8 Brown L, Rosner B, Willett W W, Sacks F M. Cholesterol-lowering effects of dietary fiber: a meta-analysis.  Am J Clin Nutr. 1999;  69 30-42
    PubMedGoogle Scholar
  • 9 Brunner E J, Wunsch H, Marmot M G. What is an optimal diet? Relationship of macronutrient intake to obesity, glucose tolerance, lipoprotein cholesterol levels and the metabolic syndrome in the Whitehall II study.  Int J Obesity. 2001;  25 45-53
    PubMedGoogle Scholar
  • 10 Burr M L, Gilbert J F, Holliday R M, Elwood P C, Fehily A M, Rogers S, Sweetnam P M, Deadman N M. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).  The Lancet. 1989;  2 757-761
    PubMedGoogle Scholar
  • 11 Clarke S D. Polyunsaturated Fatty Acid Regulation of Gene Transcription: A Molecular Mechanism to Improve the Metabolic Syndrome.  J Nutr. 2001;  131 1129-1132
    PubMedGoogle Scholar
  • 12 De Caterina R, Libby P. Control of Endothelial Leukocyte Adhesion Molecules by Fatty Acids.  Lipids. 1996;  31 57-63
    PubMedGoogle Scholar
  • 13 Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (Hrsg) .Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main; Umschau/Braus 2000
    Google Scholar
  • 14 Fielding C J, Havel R J, Todd K M, Yeo K E, Schloetter M C, Weinberg V, Frost P H. Effects of Dietary Cholesterol and Fat Saturation on Plasma Lipoproteins in an Ethnically Diverse Population of Healthy Young Men.  J Clin Invest. 1995;  95 611-618
    PubMedGoogle Scholar
  • 15 Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.  JAMA. 2002;  287 356-359
    CrossrefPubMedGoogle Scholar
  • 16 Fuentes F, Lopez-Mirand J. et al . Mediterranean and Low-Fat Diets Improve Endothelial Function in Hypercholesterolemic Men.  Ann Intern Med. 2001;  134 115-1119
    PubMedGoogle Scholar
  • 17 Gey K F, Puska P, Jordan P, Moser U K. Inverse correlation between plasma vitamin E and mortality from isichemic heart disease incross-cultural epidemiology.  Am J Clin Nutr. 1991;  53 326-345
    PubMedGoogle Scholar
  • 18 GISSI-Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.  Lancet. 1999;  354 447-455
    CrossrefPubMedGoogle Scholar
  • 19 Hertog M GL, Feskens E JM, Hollman P CH. et al . Dietary antioxidant flavonoids and risk of coronary heart disease; the Zutphen Elderly Study.  Lancet. 1993;  342 1007-1011
    CrossrefPubMedGoogle Scholar
  • 20 Hokanson J E, Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies.  J of Cardiovascular Risk. 1996;  3 213-219
    CrossrefPubMedGoogle Scholar
  • 21 Hooper L, Summerbell C D, Higgins J PT. et al . Dietary fat intake and prevention of cardiovascular disease: systematic review.  BMJ. 2001;  322 757-763
    CrossrefPubMedGoogle Scholar
  • 22 Hooper L, Ness A, Higgins J PT. et al . Letter to the editor.  Lancet. 1999;  354 1557
    PubMedGoogle Scholar
  • 23 Hu F B, Rimm E B, Stampfer M J. et al . Prospective study of major dietary patterns and risk of coronary heart disease in men.  Am J Clin Nutr. 2000;  72 912-921
    PubMedGoogle Scholar
  • 24 Joshipura K J. et al . The Effect of Fruit and Vegetable Intake on Risk for Coronary Heart Disease.  Ann Intern Med. 2001;  134 1106-1114
    CrossrefPubMedGoogle Scholar
  • 25 Jump D B, Clarke S D. Regulation of gene expression by dietary fat.  Annu Rev Nutr. 1999;  19 63-90
    CrossrefPubMedGoogle Scholar
  • 26 Kaminski W E, Jendraschak E, Kiefl R, von Schacky C. Dietary n-3 Fatty Acids Lower Levels of Platelet-Derived Growth Factor mRNA in Human Mononuclear Cells.  Blood. 1993;  81 1871-1879
    PubMedGoogle Scholar
  • 27 Katan M B, Zock P L, Mensink R P. Effects of fats and fatty acids on blood lipids in humans: an overview.  Am J Clin Nutr. 1994;  60 1017-1022
    PubMedGoogle Scholar
  • 28 Katan M B, Beynen A C. Hyper-response to dietary cholesterol in man.  The Lancet. 1983;  28 1213
    PubMedGoogle Scholar
  • 29 Keys A J, Anderson J T, Grande F. Serum cholesterol responses to changes in the diet. IV. Particular saturated fatty acids in the diet.  Metabolism. 1965;  14 776-786
    CrossrefPubMedGoogle Scholar
  • 30 Knopp R H, Walden C E, Retzlaff B M. et al . Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study.  JAMA. 1998;  6 1345-1346
    PubMedGoogle Scholar
  • 31 Kushi L, Folsom A, Prineas R, Mink P, Wu J, Bostick R. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.  N Engl J Med. 1996;  334 1156-1162
    CrossrefPubMedGoogle Scholar
  • 32 Law M R, Wald N J, Thompson S G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?.  BMJ. 1994;  308 367-373
    PubMedGoogle Scholar
  • 33 Lee C D, Blair S N, Jackson A S. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men.  Am J Clin Nutr. 1999;  69 373-380
    CrossrefPubMedGoogle Scholar
  • 34 Leelarthaepin B, Woodhill J M, Palmer A J, Blacket R B. Obesity, diet, and type-II hyperlipidemia.  Lancet. 1974;  2 1217-1221
    PubMedGoogle Scholar
  • 35 Lewis B. Conference: Health effects of blood lipids - IX. Diet: Lipoprotein and lipid responses to unfactorial and multifactorial dietary change.  Prev Med. 1979;  8 695-703
    PubMedGoogle Scholar
  • 36 Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.  Lancet. 1994;  343 1454-1459
    CrossrefPubMedGoogle Scholar
  • 37 Mistry P, Miller N E, Laker M, Turner P R, Lewis B. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man.  J Clin Invest. 1981;  67 493-499
    PubMedGoogle Scholar
  • 38 Napoli C, D'Armiento F P, Mancini F P, Postiglione A, Witztum J L, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.  J Clin Invest. 1997;  100 2680-2690
    CrossrefPubMedGoogle Scholar
  • 39 Oomen C M, Ocke M C, Feskens E JM, van Erp-Baart M J, Kok F J, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study.  Lancet. 2001;  357 746-751
    CrossrefPubMedGoogle Scholar
  • 40 Pekkanen J, Linn S. et al . Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.  New Eng J Med. 1990;  322 1700-1707
    CrossrefPubMedGoogle Scholar
  • 41 Rimm E B, Ascherio A, Giovannucci E, Spiegelmann D, Stampfer J, Willett W C. Vegetable, Fruit, and Cereal Fiber Intake and Risk of Coronary Heart Disease Among Men.  JAMA. 1996;  275 447-451
    CrossrefPubMedGoogle Scholar
  • 42 Rivellese A A, Auletta P, Marotta G, Saldalamacchia G, Giacco A, Mastrilli V, Vaccaro O, Riccardi G. Long-term metabolic effects of two dietary methods of treating hyperlipidaemia.  BMJ. 1994;  308 227-231
    PubMedGoogle Scholar
  • 43 Saynor R, Gillott T. Changes in Blood Lipids and Fibrinogen with a Note on Safety in a Long Term Study on the Effects of n-3 Fatty Acids in Subjects Receiving Fish Oil Supplements and Followed for Seven Years.  Lipids. 1992;  27 533-538
    CrossrefPubMedGoogle Scholar
  • 44 Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, Drinkmann A, Bacher F, Grunze M, Kübler M. Regular Physical Exercise and Low-Fat Diet. Effects on Progression of Coronary Artery Disease.  Circulation. 1992;  86 1-11
    PubMedGoogle Scholar
  • 45 Siscovick D S, Raghunathan T, Kind I. et al . Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.  J Am Med Assoc. 1995;  274 1363-1367
    CrossrefPubMedGoogle Scholar
  • 46 Stamler J, Stamler R, Neaton J D. et al . Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.  JAMA. 1999;  282 2012-2018
    CrossrefPubMedGoogle Scholar
  • 47 Stevinson C, Pittler M H, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomised clinical trials.  Ann Int Med. 2000;  133 420-429
    PubMedGoogle Scholar
  • 48 Thefeld W. Verbreitung der Herz-Kreislauf-Risikofaktoren Hypercholesterinämie, Übergewicht, Hypertonie und Rauchen in der Bevölkerung.  Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz. 2000;  43 415-423
    PubMedGoogle Scholar
  • 49 Temme E H, Mensink R P, Hornstra G. Effects of diets enriched in lauric, palmitic or oleic acids on blood coagulation and fibrinolysis.  Thromb Haemost. 1999;  81 (2) 259-263
    PubMedGoogle Scholar
  • 50 Toborek M, Lee Y W, Garrido R, Kaiser S, Henning B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells.  Am J Clin Nutr. 2002;  75 119-125
    PubMedGoogle Scholar
  • 51 Weggemans R M, Zock P L, Katan M B. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis.  Am J Clin Nutr. 2001;  73 885-891
    PubMedGoogle Scholar
  • 52 Weststrate J A, Meijer G W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects.  E J Clin Nutr. 1998;  52 334-343
    PubMedGoogle Scholar
  • 53 Witztum J L, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis.  J Clin Invest. 1991;  88 1785-1792
    CrossrefPubMedGoogle Scholar
  • 54 Wolfram G. Prävention der Arteriosklerose.  Akt Ernähr-Med. 1995;  20 255-259
    PubMedGoogle Scholar
  • 55 Wolfram G. Was sind und wie wirken n-3-Fettsäuren?.  Ern-Umschau. 1997;  44 (Sonderheft) 36-41
    PubMedGoogle Scholar
  • 56 Wolfram G. Dyslipoproteinämien. In: Biesalski HK et al (Hrsg) Vitamine. Stuttgart; Thieme Verlag 1999
    Google Scholar
  • 57 Wolfram G, Fremann D. Krankheitsprophylaxe mit vollwertiger Ernährung. In: Deutsche Gesellschaft für Ernährung (Hrsg) Ernährungsbericht 2000. Frankfurt; Druckerei Henrich 2000
    Google Scholar
  • 58 Wolfram G, Fremann D. Referenzwerte mit Gewähr - Richtwerte für die Fettzufuhr.  Ernährungs-Umschau. 2001;  48 274-283
    PubMedGoogle Scholar
  • 59 Wolfram G. Ernährungstherapie. In: Schwandt P, Richter WO, Parhofer KG (Hrsg) Handbuch der Fettstoffwechselstörungen. Stuttgart; Schattauer Verlag 2001
    Google Scholar
  • 60 Zock P L, Katan M B. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans.  J Lipid Res. 1991;  33 399-410
    PubMedGoogle Scholar
  • 61 Zock P L, Katan M B, Merkus M P, van Dusseldorp M, Harryvan J L. Effect of a lipid-rich fraction from boiled coffee on serum cholesterol.  Lancet. 1990;  335 1235-1237
    CrossrefPubMedGoogle Scholar

Prof. Dr. G. Wolfram

Institut für Ernährungswissenschaft · Techn. Universität München

85350 Freising-Weihenstephan

      >